"Navigating the Modern News Zoo so you don't have to."
Wednesday, September 17, 2025
Semaglutide provides powerful protection against diabetic retinopathy, study suggests
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published in the journal Pharmaceutics.
The ATF Might Be Evolving - This is NOT Good
- Cenk Admits People At TPUSA Event Treated Him With Respect - Hailey Gomez
- How Small Businesses Are Navigating Economic Uncertainty
- Elon Musk's Ambitious Plan: To Send One Million Humans to Mars within the Next Decade - Michael A. Medeiros
- Horrifying screwworm infection confirmed in US traveler after overseas trip - Beth Mole
- The Evolution and Impact of Internet Jokes: A Closer Look at Prank.Chat - Bertha Stephens
- The Full Moons of 2024: A Comprehensive Guide to Their Names and Dates - Arya Chandran
Why Budget Smartphones In 2025 Just S@ck!
- Ensuring Greater Trust in Mail-in Voting - Paul Calem
- Charlie Kirk Respected You - Kathryn Jean Lopez
- What Adding Turmeric to Your Diet Does for Weight Loss - Emmanuella Ogbonna
- Not a Bad Thing: Remember All Those Electric Buses Kamala Paid For and We Didn't Get?
- iOS 18 Elevates the iPhone with Unmatched Personalization and Intelligence - Michael A. Medeiros
- Marvel And Star Trek Stars Face Backlash For Condeming Charlie Kirk's Slaying - Joshua Tyler
